Stories from Mainz · Germany

Two men participated in the Mainz-Heibmarathon wearing complete firefighter gear, including breathing apparatus and oxygen masks. The event took place in Mainz. The source mentioned they were fit and finished the race.

A group has committed targeted bank robberies across Germany using a consistent modus operandi. This method involves selecting banks near train stations, arriving by public transport, and separating during their escape. A recent attempt in Mainz failed.

A series of targeted bank robberies have been committed across Germany, utilizing a consistent modus operandi. The perpetrators selected financial institutions near train stations, traveled by public transport, and then separated during their escape after the robbery.

New findings have emerged regarding an alleged hostage-taking incident at a bank branch in Rhineland-Palatinate, Germany. Investigators now believe there was at least one perpetrator involved. It is also considered probable that loot was taken during the incident.

BioNTech is expected to shut down CureVac completely following its acquisition of the company. The acquisition followed previous patent infringement allegations made by CureVac against BioNTech regarding mRNA technology.

The Rhineland-Palatinate state parliament passed a constitutional amendment during its most recent session today. The amendment changes the rules governing parliamentary committees of inquiry. The decision was made by the Landtag in its latest sitting.

BioNTech's long-term profitability depends on the effectiveness of its current cancer therapy research pipeline. The company maintains cash reserves, allowing for continued high spending on research and development.

BioNTech announced the unexpected departure of its co-founders, a German research couple of Turkish origin. The founders previously focused on RNA innovation. The group now intends to concentrate on the oncology sector. BioNTech was founded in 2008.

The IG Bergbau Chemie union criticized BioNTech's plan to close locations, calling it a lack of social responsibility and an attack on employees. The union noted that BioNTech earned billions during the COVID-19 pandemic and received millions in state support.

BioNTech management announced in Mainz today plans to close several production sites. The move is expected to affect up to 1,000 employees. The company previously acquired CureVac, a competitor based in Tübingen, last year.